The Canadian Medical Marijuana Program began out of the need to provide those with qualifying medical conditions the possibility to connect with designated medical marijuana growers
Ulcerative colitis, one of the most well known irritable bowel diseases, can cause severe fatigue, urgent diarrhea, pain, loss of appetite and unhealthy weight loss.
Cannabis, otherwise known as marijuana (or marihuana), has been a topic of debate for many years, not only in Canada, but also in several other countries including the U.S.
This website follows the Health Canada Guidelines to offer you support and the resources you need to become license to possess marijuana for qualified medical conditions, or to become licensed to produce medical marijuana to supply a qualified patient.
The Canadian Medical Marijuana Program began out of the need to provide those with qualifying medical conditions the possibility to connect with designated medical marijuana growers… and vice versa. The information provided on this website comes from a variety of News sources, Health Canada directly, Medical Practitioners and currently licensed patients across Canada. This website is a way to connect and stay up to date on the past events, current event and possible future events within this industry.
Ulcerative colitis, one of the most well known irritable bowel diseases, can cause severe fatigue, urgent diarrhea, pain, loss of appetite and unhealthy weight loss. Many of the traditional medicinal treatments have side effects much like ulcerative colitis itself, with severe side effects from long-term use.
Most patients with ulcerative colitis (and their doctors for that matter), believed they were stuck with traditional medication treatments. The side effects were just one more issue on top of a severe medical problem with no final solution or cure. The same can be said for several diseases: multiple sclerosis, cancer and other patients believed that, to have a better quality of life, they needed the traditional treatments – even if those treatments were sometimes worse than the actual disease.
As medicinal marijuana laws change, however, another treatment is being bandied about – not by the medical profession, but by those patients using cannabis as a way to relieve symptoms and reduce (or omit) the need for pharmaceutical medication. Ulcerative colitis sufferers are no different.
Cannabis, otherwise known as marijuana (or marihuana), has been a topic of debate for many years, not only in Canada, but also in several other countries including the U.S. and the U.K. However, while marijuana for recreational use has not been legalized in Canada, medical marijuana use can be granted for medical needs such as grave or debilitating illnesses.
The Definition of Chronic Pain
Although “chronic pain” seems all encompassing and thus easily used as a reason for medical marijuana use, the organization of Health Canada very clearly defines what can be considered severe enough pain for medical marijuana. With that said, there are many suffering from chronic pain – due to a variety of reasons – with grants for the medical use of cannabis.
Throughout man’s history marijuana has always been known as one of the most therapeutic plants in the world.
Marijuana is not addictive.
Our research, backed by hundreds of other studies done worldwide, has proven properly made marijuana medicine provides relief for HIV/Aids patients. Throughout thousands of years of medicinal use marijuana has been known as a cure-all and not without good reason. We have provided marijuana medicine to hundreds of people with various medical conditions and the results speak for themselves.
Millions of people enjoy smoking marijuana, but this is the least effective way to use the plant medicinally. The real medical miracles occur when the marijuana is ingested, drank in tea, cooked in cookies/brownies or used topically on skin infections or diseases – then watch what happens! Marijuana is real medicine straight from Mother Nature, not some concoction of chemicals and poisons produced in a pill factory somewhere.